DARE
Price
$2.71
Change
-$0.27 (-9.06%)
Updated
Dec 20 closing price
SNTI
Price
$3.97
Change
-$0.01 (-0.25%)
Updated
Dec 20 closing price
Ad is loading...

DARE vs SNTI

Header iconDARE vs SNTI Comparison
Open Charts DARE vs SNTIBanner chart's image
Dare Bioscience
Price$2.71
Change-$0.27 (-9.06%)
Volume$89.98K
CapitalizationN/A
Senti Biosciences
Price$3.97
Change-$0.01 (-0.25%)
Volume$190.88K
CapitalizationN/A
DARE vs SNTI Comparison Chart
Loading...
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DARE vs. SNTI commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DARE is a Hold and SNTI is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (DARE: $2.71 vs. SNTI: $3.97)
Brand notoriety: DARE and SNTI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DARE: 156% vs. SNTI: 6%
Market capitalization -- DARE: $23.53M vs. SNTI: $19.09M
DARE [@Biotechnology] is valued at $23.53M. SNTI’s [@Biotechnology] market capitalization is $19.09M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DARE’s FA Score shows that 0 FA rating(s) are green whileSNTI’s FA Score has 1 green FA rating(s).

  • DARE’s FA Score: 0 green, 5 red.
  • SNTI’s FA Score: 1 green, 4 red.
According to our system of comparison, SNTI is a better buy in the long-term than DARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DARE’s TA Score shows that 4 TA indicator(s) are bullish while SNTI’s TA Score has 5 bullish TA indicator(s).

  • DARE’s TA Score: 4 bullish, 6 bearish.
  • SNTI’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SNTI is a better buy in the short-term than DARE.

Price Growth

DARE (@Biotechnology) experienced а -14.78% price change this week, while SNTI (@Biotechnology) price change was -28.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

Reported Earning Dates

DARE is expected to report earnings on Aug 08, 2024.

SNTI is expected to report earnings on Aug 12, 2024.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DARE($23.5M) has a higher market cap than SNTI($19.1M). DARE YTD gains are higher at: -26.915 vs. SNTI (-39.848). DARE has higher annual earnings (EBITDA): -23.19M vs. SNTI (-57.12M). DARE has more cash in the bank: 11.2M vs. SNTI (10.5M). DARE has less debt than SNTI: DARE (1.4M) vs SNTI (34.7M). DARE has higher revenues than SNTI: DARE (1.88M) vs SNTI (0).
DARESNTIDARE / SNTI
Capitalization23.5M19.1M123%
EBITDA-23.19M-57.12M41%
Gain YTD-26.915-39.84868%
P/E Ratio0.10N/A-
Revenue1.88M0-
Total Cash11.2M10.5M107%
Total Debt1.4M34.7M4%
FUNDAMENTALS RATINGS
DARE: Fundamental Ratings
DARE
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
83
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DARESNTI
RSI
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
60%
Momentum
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
50%
MACD
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
71%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
50%
Advances
ODDS (%)
Bullish Trend 12 days ago
79%
Bullish Trend 21 days ago
73%
Declines
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
54%
Aroon
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
74%
View a ticker or compare two or three
Ad is loading...
DARE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNTI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PFG77.302.12
+2.82%
Principal Financial Group
PKBK21.190.35
+1.68%
Parke Bancorp
IRT20.190.28
+1.41%
Independence Realty Trust
BFS38.660.43
+1.12%
Saul Centers
NRXP1.50-0.02
-1.32%
NRX Pharmaceuticals

DARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, DARE has been closely correlated with AZTR. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if DARE jumps, then AZTR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DARE
1D Price
Change %
DARE100%
-9.06%
AZTR - DARE
73%
Closely correlated
+5.01%
CYTK - DARE
42%
Loosely correlated
+4.56%
AXON - DARE
39%
Loosely correlated
+2.60%
AMRN - DARE
34%
Loosely correlated
-1.18%
SNTI - DARE
32%
Poorly correlated
-0.25%
More